Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions Inc (BLFS)
:BLFS
BLFS Stock Chart & Stats
$25.93
-$0.09(-0.33%)
At close: 4:00 PM EST
$25.93
-$0.09(-0.33%)
Day’s Range― - ―
52-Week Range$19.10 - $29.62
Previous CloseN/A
Volume44.73K
Average Volume (3M)357.97K
Market Cap
$1.32B
Enterprise ValueN/A
Total Cash (Recent Filing)$78.95M
Total Debt (Recent Filing)$20.68M
Price to Earnings (P/E)―
Beta1.72
Next Earnings
Mar 12, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding47,905,266
10 Day Avg. Volume331,518
30 Day Avg. Volume357,970
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)3.43
Price to Sales (P/S)14.54
P/FCF Ratio229.80
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$32.00Price Target Upside23.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial GuidanceManagement raised the 2025 revenue guidance to $100-103M, indicating confidence in continued growth and performance.
Revenue GrowthBioLife Solutions achieved strong revenue growth, with a 29% increase year-over-year in the second quarter, exceeding projections.
Strategic AcquisitionsAcquisitions, such as the purchase of PanTHERA CryoSolutions, help solidify BioLife's leadership position in the biopreservation and cell and gene therapies market.
Bears Say
Gross MarginsGross margins fell a bit in the second quarter, to 62% from 64%.
BioLife Solutions News
BLFS FAQ
What was BioLife Solutions Inc’s price range in the past 12 months?
BioLife Solutions Inc lowest stock price was $19.10 and its highest was $29.62 in the past 12 months.
What is BioLife Solutions Inc’s market cap?
BioLife Solutions Inc’s market cap is $1.32B.
When is BioLife Solutions Inc’s upcoming earnings report date?
BioLife Solutions Inc’s upcoming earnings report date is Mar 12, 2026 which is in 124 days.
How were BioLife Solutions Inc’s earnings last quarter?
BioLife Solutions Inc released its earnings results on Nov 06, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.012 by $0.022.
Is BioLife Solutions Inc overvalued?
According to Wall Street analysts BioLife Solutions Inc’s price is currently Undervalued.
Does BioLife Solutions Inc pay dividends?
BioLife Solutions Inc does not currently pay dividends.
What is BioLife Solutions Inc’s EPS estimate?
BioLife Solutions Inc’s EPS estimate is >-0.01.
How many shares outstanding does BioLife Solutions Inc have?
BioLife Solutions Inc has 47,905,266 shares outstanding.
What happened to BioLife Solutions Inc’s price movement after its last earnings report?
BioLife Solutions Inc reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.012. Following the earnings report the stock price went down -4.034%.
Which hedge fund is a major shareholder of BioLife Solutions Inc?
Currently, no hedge funds are holding shares in BLFS
BioLife Solutions Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.00 (23.41% Upside)
$32.00 (23.41% Upside)
Blogger Sentiment
Bullish
BLFS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 301.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $45.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.80%
12-Months-Change
Fundamentals
Return on Equity
-5.98%
Trailing 12-Months
Asset Growth
3.27%
Trailing 12-Months
Company Description
BioLife Solutions Inc
BioLife Solutions (BLFS) is a leading provider of proprietary biopreservation tools and services for the cell and gene therapy sectors. The company specializes in the development and production of biopreservation media, cryopreservation solutions, and storage systems that ensure the viability and functionality of biologic materials during storage and transportation. Its core products include CryoStor, HypoThermosol, and other proprietary solutions designed to optimize the preservation of cellular therapies, tissue, and organs for transplantation.
BLFS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
BioLife Solutions demonstrated solid revenue growth and improved profitability, with strategic moves like the sale of the evo Cold Chain product line strengthening their financial position. However, challenges such as a decline in adjusted gross margin and increased operating expenses were noted. The overall sentiment is positive due to the strong growth metrics and strategic focus on core competencies.View all BLFS earnings summariesBLFS Revenue Breakdown
45.91% Cell processing
36.05% Freezer and thaw
18.04% Biostorage services
BLFS Stock 12 Month Forecast
Average Price Target
$32.00
▲(23.41% Upside)
Technical Analysis
Azenta
―
Staar Surgical
―
Pulse Biosciences
―
Sanara MedTech
―
Kestra Medical Technologies Ltd.
―
Ownership Overview
15.92% Insiders
30.53% Mutual Funds
0.35% Other Institutional Investors
36.81% Public Companies and
Individual Investors